Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension

European Journal of Cardio-thoracic Surgery

Volumn 46, Issue 5, 2014, Pages 818-824

  Wilbring, Manuel ^a   Tugtekin, Sems Malte ^a   Ritzmann, Mike ^a   Arzt, Sebastian ^a   Schmidt, Torsten ^a   Matschke, Klaus ^a   Kappert, Utz ^a   Alexiou, Konstantin ^a  

^a University Heart Center Dresden   (Germany)

Author keywords

Mitral regurgitation; RVESP; TAPSE; TAVI; Tricuspid regurgitation

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EUROSCORE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VALVE BIOPROSTHESIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RIGHT VENTRICULAR ENDSYSTOLIC PRESSURE; RIGHT VENTRICULAR SYSTOLIC PRESSURE; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION; TRICUSPID VALVE REGURGITATION; ADVERSE EFFECTS; HEMODYNAMICS; KAPLAN MEIER METHOD; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; MALE; MITRAL VALVE INSUFFICIENCY; POSTOPERATIVE COMPLICATIONS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME; TRICUSPID VALVE INSUFFICIENCY;

EID: 84925484863     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezu037     Document Type: Article

References (18)

1. Cribier A, Eltchaninoff H, Borenstein N, Tron C, Bauer F, Derumeaux G et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106:3006-8.
2. Hutter A, Bleiziffer S, Richter V, Opitz A, Hettich I, Mazzitelli D et al. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation. Ann Thorac Surg 2013;95:77-84.
3. D'Onofrio A, Gasparetto V, Napodano M, Bianco R, Tarantini G, Renier V et al. Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. Eur J Cardiothorac Surg 2012;41: 1271-6.
4. Ben-Dor I, Goldstein SA, Pichard AD, Satler LF, Maluenda G, Li Y et al. Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol 2011;107:1046-51.
5. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-23.
6. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63.
7. Tzikas A, Piazza N, van Dalen BM, Schultz C, Geleijnse ML, van Geuns RJ et al. Changes in mitral regurgitation after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010;75:43-9.
8. Barreiro CJ, Patel ND, Fitton TP, Williams JA, Bonde PN, Chan V et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation 2005; 112:I443-7.
9. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH et al. Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 2012;42:S45-60.
10. Wilbring M, Alexiou K, Tugtekin SM, Sill B, Simonis G, Matschke K et al. Transcatheter valve-in-valve therapies: patient selection, prosthesis assessment and selection, results, and future directions. Curr Cardiol Rep 2013;15:341.
11. Wilbring M, Tugtekin SM, Alexiou K, Simonis G, Matschke K, Kappert U. Transapical transcatheter aortic valve implantation vs conventional aortic valve replacement in high-risk patients with previous cardiac surgery: a propensity-score analysis. Eur J Cardiothorac Surg 2013;44:42-7.
12. Wilbring M, Alexiou K, Tugtekin SM, Sill B, Hammer P, Schmidt T et al. Transapical transcatheter valve-in-valve implantation for deteriorated mitral valve bioprostheses. Ann Thorac Surg 2013;95:111-7.
13. Wilbring M, Sill B, Tugtekin SM, Alexiou K, Simonis G, Matschke K et al. Transcatheter valve-in-valve implantation for deteriorated aortic bioprosthesis: initial clinical results and follow-up in a series of high-risk patients. Ann Thorac Surg 2012;93:734-41.
14. Alexiou K, Wilbring M, Nguyen M, Tugtekin SM, Kappert U, Matschke K. Transcatheter aortic valve implantation reduces grade of concomitant mitral-and tricuspid valve regurgitation and improves right ventricular function. Thorac Cardiovasc Surg 2013:61-P71.
15. Toggweiler S, Boone RH, Rodés-Cabau J, Humphries KH, Lee M, Nombela-Franco L et al. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol 2012;59:2068-74.
16. Toggweiler S, Humphries KH, Lee M, Binder RK, Moss RR, Freeman M et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 2013;61:413-9.
17. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol 2012;60:1864-75.
18. Giordana F, Capriolo M, Frea S, Marra WG, Giorgi M, Bergamasco L et al. Impact of TAVI on mitral regurgitation: a prospective echocardiographic study. Echocardiography 2013;30:250-7.